Primary Site >> Liver Cancer
Gene >> BMX
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine. PMID: 9252136 |
Ref: Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma. PMID: 16077978 |
Ref: Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma. PMID: 18196928 |
Ref: Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. PMID: 19290923 Ref: Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. PMID: 19363518 |
Ref: Suppression of Etk/Bmx protects against ischemic brain injury. PMID: 21929872 |
Ref: An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. PMID: 24992166 Ref: Feasibility of Single-Input Tracer Kinetic Modeling with Continuous-Time Formalism in Liver 4-Phase Dynamic Contrast-Enhanced CT. PMID: 26236779 Ref: Current understanding of tyrosine kinase BMX in inflammation and its inhibitors. PMID: 27602372 |
Ref: Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy. PMID: 26366997 |